Skip to content

To study the effect of Pavanari Rasa for pain management in Amavata.

Clinical study of Pavanari Rasa on pain in patients of Amavata with special reference to Rheumatoid arthritis - a randomised controlled trial . - nill

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055293
Enrollment
40
Registered
2023-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M04-M04- Autoinflammatory syndromes

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to sign consent form for the clinical trial. 2. Patients between the age group of 25 to 60 years, irrespective of sex and socio-economic status. 3. Patients having signs and symptoms of â??Amavataâ?? (Rheumatoid Arthritis) 4. Patients fulfill the criteria of ACR / EULAR 2010 criteria (American College of Rheumatology /European League Against Rheumatism) 5. Patients with chronicity of less than 5 years.

Exclusion criteria

Exclusion criteria: 1. Patients having severe joint deformities. 2. Patients having age 60 years . 3. Patients suffering from paralysis. 4. Patients having any type of arthropathy such as Neoplasm of spine, Gout, Ankylosing spondylosis, Traumatic arthritis and Pyogenic osteomyelitis etc. 5. Patients having associated Cardiac disease, Tuberculosis, Diabetes mellitus, Malignant Hypertension, Renal Function Impairment, Hypothyroidism, Rheumatic Heart Disease etc. 6. Patients with extremely reduced joint space. 7. Pregnant women and lactating mother. 8. Patient taking disease modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis.

Design outcomes

Primary

MeasureTime frame
Changes in Pain score.Timepoint: 14 days

Secondary

MeasureTime frame
Changes in symptoms of Amavata, Improvement in quality of life and changes in DAS-28 score, CRP, RA Factor, Disability Index Score, other symptoms, Improvement in walking time,hand &foot grip.Timepoint: 30 days

Countries

India

Contacts

Public ContactDr Ajay Kumar Sahu

National Institute Of Ayurveda, Jaipur,Rajasthan

drajaysahu@gmail.com9950708106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026